BC
WGS icon

Bridgefront Capital’s GeneDx Holdings WGS Stock Holding History

Bridgefront Capital’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313K Sell
4,561
-851
-16% -$48.4K 0.08% 369
2026
Q1 		$348K Buy
+5,412
New +$494K 0.09% 352

Other funds holding WGS

Corvex Management
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Bridgefront Capital's WGS Position: Q2 2026 in Review

Bridgefront Capital reduced its GeneDx Holdings (WGS) stake by 16% in Q2 2026, selling an estimated $48.4K and leaving 4,561 shares worth $313K. The position accounts for 0.08% of the portfolio, ranked #369.

Bridgefront Capital first reported a position in WGS in Q1 2026 and has held it in 2 quarters since. The position peaked at $348K in Q1 2026. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Bridgefront Capital held 4,561 shares of GeneDx Holdings worth $313K as of Q2 2026.
  • Bridgefront Capital sold 851 GeneDx Holdings shares in Q2 2026, an estimated $48.4K.
  • GeneDx Holdings made up 0.08% of Bridgefront Capital's portfolio in Q2 2026, its #369 holding.
  • Bridgefront Capital first reported a position in GeneDx Holdings in Q1 2026 and has held it in 2 quarters since.
  • Bridgefront Capital's GeneDx Holdings position peaked at $348K in Q1 2026.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.